Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results

Click here to go back to your search results.

Kidney Cancer treatment details. Immunotherapy. Edward Hines Jr VA Hospital, Illinois, United States

Survival: 13.0 months
Toxicity Grade: 4
Treatments: Immunotherapy
Country: United States
City/State/Province: Illinois
Hospital: Edward Hines Jr VA Hospital
Journal: Link
Date: 4/2002

Patients: This Phase II study involved 44 patients with metastatic renal cell carcinoma; 32 men and 12 women. The median age was 56 years. Prior treatments had included nephrectomy (19 patients) and radiation therapy (5 patients).

Treatment: The treatment consisted of immunotherapy interleukin-2 (IL-2) and interferon alpha-2b (IFN alpha-2b).

Toxicity: Grade 3-4 toxicities included hematologic, hyponatremia, hepatic, metabolic, gastrointestinal, nausea, diarrhea, stomatitis, renal, hypotension, neurologic, and dyspnea.

Results: The median survival was 13 months.

Support: The study was supported by grants from Chiron Therapeutics and Schering Plough Corporation. Chiron holds a patent on IL-2 and Schering Plough markets IFN alpha-2b.

Correspondence: Dr. J.I. Clark

E-mail to a Friend Email Physician More Information